Altana Pharma Sues Sun Again Over Heartburn Drug Patent

Law360, New York (August 18, 2005, 12:00 AM EDT) -- German drug maker Altana Pharma AG and its U.S. partner Wyeth Pharmaceuticals are once again suing Mumbai, India-based Sun Pharmaceuticals over plans to make generic versions of a popular drug for severe heartburn.

The new complaint, filed in U.S. District Court for New Jersey, addresses Sun’s alleged infringement of a patent used in covering a specific dosage and distribution method of Altana’s medication Protoxin.

In June, compelled by requirements in the Hatch-Waxman Act, Sun notified Altana and Wyeth of its intentions to create the generic version...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.